This article first appeared on GuruFocus .
-
Net Sales:$499 million, up 3% (2.8%, +$14 million) year over year, driven by Performance Chemicals and Class I crosstie volumes; favorable currency impact of $6 million.
-
Adjusted EBITDA:$58 million, down 18% ($13 million) year over year, on higher raw material and logistics costs and higher SG&A.
-
Adjusted EBITDA Margin:11.6% versus 14.6% in the prior year quarter.
-
Adjusted EPS:$0.77 versus $1.21 in the prior year quarter; higher tax rate had a $0.07 negative impact.
-
Input Cost Impact:Estimated $16 million year-over-year headwind in Q3, led by CM&C raw materials.
-
SG&A Expenses:Up $3.4 million year over year on compensation and technology costs.
-
Operating Cash Flow:Record $127 million for first nine months, up from $77 million prior year.
-
Free Cash Flow:Record $92 million year-to-date versus prior year; Q3 free cash flow of $19 million versus $38 million.
-
RUPS Segment:Net sales flat at $233 million; adjusted EBITDA of $22 million versus $29 million, on lower crosstie pricing and ~$4 million higher costs.
-
Performance Chemicals Segment:Net sales up $18 million on 10% volume growth; adjusted EBITDA up $4 million to $30 million despite ~$5 million higher raw materials.
-
CM&C Segment:Sales down $3 million (8% volume decline); adjusted EBITDA of $6 million, down 61% ($10 million), on $9 million higher raw material costs; carbon pitch prices up ~4%.
-
Utility Pole Business:5% sales growth in Q3 and 11% year-to-date.
-
Catalyst Benefits:$42 million year-over-year through September ($8M PC, $13M RUPS, $11M CM&C, $10M corporate).
-
Capital Expenditures:$35 million year-to-date; full-year forecast lowered to ~$50 million from $55 million.
-
Capital Returns:$34 million debt paydown, $51 million share repurchases, $5 million dividends year-to-date; quarterly dividend raised 12.5% to $0.09 per share.
-
Liquidity & Leverage:$360 million available liquidity; $845 million net debt; net leverage of 3.7x.
-
2026 Guidance:Sales of $1.9 billion; adjusted EBITDA of $220 million-$225 million; adjusted EPS of $3.10-$3.25; free cash flow of $115 million-$135 million.
-
Warning! GuruFocus has detected 3 Warning Sign with BOM:532633.
-
Is KOP fairly valued? Test your thesis with our free DCF calculator.
Release Date: November 06, 2026
For the complete transcript of the earnings call, please refer to the full earnings call transcript .
Positive Points
-
Koppers Holdings Inc ( NYSE:KOP ) generated record year-to-date operating cash flow of $127 million and free cash flow of $92 million, up significantly from the prior year.
-
Performance Chemicals delivered 10% volume growth, driven by industrial applications and market share gains in the residential business.
-
The Catalyst transformation program delivered $42 million in year-over-year benefits through September, with a raised target of an additional $90 million by 2028.
-
The Stickney facility closure is expected to yield annual adjusted EBITDA benefits of $15-$20 million and improve EPS by $1.00-$1.20, with the transition ahead of schedule.
-
Koppers Holdings Inc ( NYSE:KOP ) returned $51 million to shareholders through share repurchases and $5 million in dividends, while reducing debt by $34 million.
Negative Points
-
Adjusted EBITDA fell 18% to $58 million, and adjusted EPS dropped to $0.77 from $1.21, due to rising raw material and logistics costs.
-
CM&C segment adjusted EBITDA plunged 61% to $6 million, hurt by a $9 million increase in raw material costs and lower sales volumes.
-
RUPS segment adjusted EBITDA declined to $22 million from $29 million, pressured by lower crosstie pricing and higher costs.
-
Koppers Holdings Inc ( NYSE:KOP ) revised its 2026 earnings outlook lower, with adjusted EBITDA now expected at $220-$225 million and EPS at $3.10-$3.25.
-
Net leverage remains elevated at 3.7 times, above the long-term target of 2-3 times, limiting financial flexibility.
Q & A Highlights
Q: Which segments will benefit from the pricing actions taking effect in January 2027, and how confident is management in recovering costs? A: CEO Leroy Ball said Performance Chemicals is the most advanced, with over 80% of booked business already agreed at prices that pass through cost increases plus a bit more, effective January 1, 2027. RUPS has contractual escalators that will recover some costs at a lower level, UIP will address spot and contractual business throughout the year, and CM&C recovery is less certain due to index timing mismatches in the international business. He expressed high confidence in the PC increases and said CM&C is likely at the worst point in the price-versus-cost relationship.
Q: What drove the 18% decline in third quarter adjusted EBITDA, and how large was the input cost impact? A: CFO Eric Brenner said adjusted EBITDA fell to $58 million with an 11.6% margin versus 14.6% a year earlier, driven mainly by higher raw material and logistics costs, lower CM&C margins from network restructuring, and lower crosstie pricing. He estimated the year-over-year impact of higher input costs at $16 million in the quarter, led by CM&C raw materials, with SG&A up $3.4 million on compensation and technology costs.
Q: How should investors think about Performance Chemicals margins after the sequential decline from the second quarter peak? A: CFO Eric Brenner said PC margins peaked at roughly 22% in Q2, moderated to about 18% in Q3, and will deteriorate a bit further in Q4 due to higher raw material costs ahead of the 2027 price increases. He said margins should remain within historical averages and that the January 2027 pricing is designed to fully cover inflation across copper, oil-related additives, and logistics.
Q: What is the status of the Florence facility, and is it permanently closed? A: CEO Leroy Ball said Florence is in the process of being idled, with treating expected to finish by the end of November or by year-end, and product shipments continuing into part of 2027 before it moves to idle status. No decision has been made to permanently close the site. Completing the wind-down is expected to drive greater network efficiency in 2027.
Q: Is the lower capital expenditure guidance a new normal, and what is the outlook for 2027? A: CEO Leroy Ball said the company has no near-term large capital requirements after completing its major growth investment cycle. He expects $50 million to be the high-water mark, with 2027 likely below that, and ongoing capital needs in the $40 million to $45 million range under the current portfolio, aside from possible logistics investment on the CM&C side related to the Denmark transition.
Q: How is the company balancing share repurchases versus debt reduction in capital allocation? A: CEO Leroy Ball said the mix may end the year closer to 50/50 between buybacks and debt paydown, versus roughly 60/40 year-to-date. He noted that at least $100 million of annual free cash flow over the next three years would represent close to half of the company's market cap, supporting continued repurchases at attractive prices while also reducing leverage toward the 2x to 3x long-term target. He added that acquisitions remain a consideration, focused on UIP and Performance Chemicals.
Q: What is driving the market share recovery in Performance Chemicals, and how important is the industrial business? A: CEO Leroy Ball said the company recovered some of the significant share lost heading into 2025 and has systematically grown industrial market share over the past three to four years, with additional industrial growth already booked for 2027. He cautioned that industrial is not a needle mover, as residential remains the lion's share of the segment, and that a strong residential market is needed for a meaningful uplift.
Q: What caused the sharp decline in RUPS segment profitability, and how is the utility business performing? A: CEO Leroy Ball said the decline reflects both higher input costs and deliberate price concessions to Class I railroads to secure volume ahead of idling Florence. He noted that the utility business has expanded gross margins year over year through higher volume, favorable mix, and cost discipline, but that performance is masked within the segment. CFO Eric Brenner added that the cost impact is much larger in PC and CM&C than in rail.
Q: What is the outlook for the utility pole business and the broader utility infrastructure market? A: CEO Leroy Ball said the US utility pole business posted 5% sales growth in Q3 and 11% year-to-date, with profitability improved on higher volumes and modest price increases. He cited bullish sentiment driven by utility infrastructure investment tied to AI infrastructure, crypto mining, EVs, and manufacturing activity, with strong demand visibility from investor-owned utilities through 2027, though fiber availability and a narrow range of pole sizes create competitive procurement dynamics.
Q: How is the CM&C network transition progressing, and what benefits are expected from the Stickney closure? A: CEO Leroy Ball said tar distillation at Stickney ended September 30 and remaining chemical production was discontinued in October, ahead of the original schedule. The company has secured feedstock for the production transfer, shipped tar cargo from North America to Europe, and is supplying pitch and creosote through US terminals, with Nyborg, Denmark supplying about 75% of creosote to the railroad business in August and September. Management continues to expect annual adjusted EBITDA benefits of $15 million to $20 million and adjusted EPS improvement of roughly $1 to $1.20.
Q: Will the combined Performance Chemicals and RUPS segments reach more than 85% of sales by 2028 through organic growth or acquisitions? A: CEO Leroy Ball said the shift is expected to be primarily organic, with growth opportunities in both businesses and CM&C potentially representing a smaller portion depending on pricing and volume. He said any inorganic activity would be in PC or UIP, and that the company is on target with its portfolio mix objectives through the next couple of years.
Q: What is the updated 2026 guidance, and what underpins confidence in significant 2027 earnings improvement? A: CEO Leroy Ball said 2026 adjusted EBITDA is now forecast at $220 million to $225 million, adjusted EPS at $3.10
For the complete transcript of the earnings call, please refer to the full earnings call transcript .
